Oral toxicity of silver ions, silver nanoparticles and colloidal silver - A review

Regulatory Toxicology and Pharmacology

Volumn 68, Issue 1, 2014, Pages 1-7

  Hadrup, Niels ^a   Lam, Henrik R ^b  

^a TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

^b DHI   (Denmark)

Author keywords

Ag; Argyria; Cardiac hypertrophy; Colloidal; Nanoparticle; Neurotoxicity; Neurotransmitter; Silver; Toxicity; Toxicology

Indexed keywords

ACETATE SILVER; COLLARGOL; LIVER ENZYME; NEUROTRANSMITTER; SILVER; SILVER DERIVATIVE; SILVER NANOPARTICLE; UNCLASSIFIED DRUG;

ARGYRIA; ARTICLE; BILE DUCT DISEASE; BILIARY EXCRETION; BLOOD BRAIN BARRIER; BLOOD CHEMISTRY; CARDIOMEGALY; CARDIOVASCULAR DISEASE; DEATH; DIETARY INTAKE; FECES ANALYSIS; FECES LEVEL; GASTROINTESTINAL TOXICITY; GENOTOXICITY; GROWTH RETARDATION; HUMAN; HYPOACTIVITY; IMMUNE RESPONSE; IMMUNOTOXICITY; INTESTINE; LETHAL DOSE; LIVER TOXICITY; LYMPHOCYTIC INFILTRATION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; REPRODUCTIVE TOXICITY; SKIN DISCOLORATION; STOMACH; TISSUE DISTRIBUTION; TOXICITY TESTING; TOXICOKINETICS; TOXICOLOGY; URINARY EXCRETION; WEIGHT REDUCTION;

AG; ARGYRIA; CARDIAC HYPERTROPHY; COLLOIDAL; NANOPARTICLE; NEUROTOXICITY; NEUROTRANSMITTER; SILVER; TOXICITY; TOXICOLOGY;

ABSORPTION; ADMINISTRATION, ORAL; ANIMALS; BILE DUCTS; BODY WEIGHT; BRAIN; CARDIOVASCULAR SYSTEM; GASTROINTESTINAL TRACT; HUMANS; LIVER; METAL NANOPARTICLES; REPRODUCTION; SILVER;

EID: 84888802356     PISSN: 02732300     EISSN: 10960295     Source Type: Journal    
DOI: 10.1016/j.yrtph.2013.11.002     Document Type: Article

References (82)

1. Aaseth J., Olsen A., Halse J., Hovig T. Argyria-tissue deposition of silver as selenide. Scand. J. Clin. Lab. Invest. 1981, 41:247-251. (Copyright (C) 2013 U.S. National Library of Medicine).
2. Alexander J.W. History of the medical use of silver. Surg. Infect. (Larchmt) 2009, 10(3):289-292.
3. Bouwmeester H., Poortman J., Peters R.J., et al. Characterization of translocation of silver nanoparticles and effects on whole-genome gene expression using an in vitro intestinal epithelium coculture model. ACS Nano 2011, 5(5):4091-4103.
4. Braydich-Stolle L., Hussain S., Schlager J.J., Hofmann M.C. In vitro cytotoxicity of nanoparticles in mammalian germline stem cells. Toxicol. Sci. 2005, 88(2):412-419.
5. Carlson C., Hussain S.M., Schrand A.M., et al. Unique cellular interaction of silver nanoparticles: size-dependent generation of reactive oxygen species. J. Phys. Chem. B 2008, 112(43):13608-13619.
6. Cha K., Hong H.W., Choi Y.G., et al. Comparison of acute responses of mice livers to short-term exposure to nano-sized or micro-sized silver particles. Biotechnol. Lett. 2008, 30(11):1893-1899. 10.1007/s10529-008-9786-2.
7. Chang A.L., Khosravi V., Egbert B. A case of argyria after colloidal silver ingestion. J. Cutaneous Pathol. 2006, 33(12):809-811. 10.1111/j.1600-0560.2006.00557.x.
8. Clemente G.F., Cignarossi L., Santaroni G.P. Trace-element intake and excretion in Italian population. J. Radioanal. Chem. 1977, 37(2):549-558. 10.1007/Bf02519367.
9. Creasey M., Moffat D.B. Deposition of ingested silver in the rat kidney at different ages. Experientia 1973, 29:326-327. (Copyright (C) 2013 American Chemical Society (ACS). All Rights Reserved).
10. Dijkstra M., Havinga R., Vonk R.J., Kuipers F. Bile secretion of cadmium, silver, zinc and copper in the rat. Involvement of various transport systems. Life Sci. 1996, 59:1237-1246. (Copyright (C) 2013 U.S. National Library of Medicine).
11. East B.W., Boddy K., Williams E.D., Macintyre D., McLay A.L. Silver retention, total body silver and tissue silver concentrations in argyria associated with exposure to an anti-smoking remedy containing silver acetate. Clin. Exp. Dermatol. 1980, 5:305-311. (Copyright (C) 2013 U.S. National Library of Medicine).
12. EFSA, 2012. Guidance on selected default values to be used by the EFSA Scientific Committee, Scientific Panels and Units in the absence of actual measured data. 10 (3). European Food Safety Authority (EFSA), Parma, Italy, EFSA Journal10(3)2579, p 2579, Available from: <>. http://www.efsa.europa.eu/en/efsajournal/doc/2579.pdf.
13. Eliopoulos P., Mourelatos D. Lack of genotoxicity of silver iodide in the SCE assay in vitro, in vivo, and in the Ames/microsome test. Teratogen. Carcinog. Mutagen. 1998, 18(6):303-308.
14. Espinosa-Cristobal L.F., Martinez-Castanon G.A., Loyola-Rodriguez J.P., et al. Toxicity, distribution, and accumulation of silver nanoparticles in Wistar rats. J. Nanopart. Res. 2013, 15(6). (doi: Unsp 1702). 10.1007/S11051-013-1702-6.
15. EU, 2006. Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR) modified Opinion (after public consultation) on The appropriateness of existing methodologies to assess the potential risks associated with engineered and adventitious products of nanotechnologies. 10 March 2006 ed. The European Commission, <>, p. 1-79. http://ec.europa.eu/health/ph_risk/committees/04_scenihr/docs/scenihr_o_003b.pdf.
16. Furchner J.E., Richmond C.R., Drake G.A. Comparative metabolism of radionuclides in mammals-IV. Retention of silver-110m in the mouse, rat, monkey, and dog. Health Phys. 1968, 15:505-514. (Copyright (C) 2013 U.S. National Library of Medicine).
17. Gibson R.S., Scythes C.A. Chromium, Selenium, and Other trace-element intakes of a selected sample of Canadian premenopausal women. Biol. Trace Elem. Res. 1984, 6(2):105-116. 10.1007/Bf02916928.
18. Goebel H.H., Muller J. Ultrastructural observations on silver deposition in the choroid plexus of a patient with argyria. Acta Neuropathol. 1973, 26:247-251. (Copyright (C) 2013 U.S. National Library of Medicine).
19. Hadek R. Preliminary report on the cellular effect of intravital silver in the mouse ovary. J. Ultrastruct. Res. 1966, 15(1):66-73.
20. Hadrup N., Lam H.R., Loeschner K., Mortensen A., Larsen E.H., Frandsen H. Nanoparticulate silver increases uric acid and allantoin excretion in rats, as identified by metabolomics. J. Appl. Toxicol. 2012, 32(11):929-933. 10.1002/jat.2779.
21. Hadrup N., Loeschner K., Bergstrom A., et al. Subacute oral toxicity investigation of nanoparticulate and ionic silver in rats. Arch. Toxicol. 2012, 86(4):543-551.
22. Hadrup N., Loeschner K., Mortensen A., et al. The similar neurotoxic effects of nanoparticulate and ionic silver in vivo and in vitro. Neurotoxicology 2012, 33(3):416-423. 10.1016/j.neuro.2012.04.008.
23. Ham K.N., Tange J.D. Silver deposition in rat glomerular basement membrane. Aust. J. Exp. Biol. Med. Sci. 1972, 50:423-434. (Copyright (C) 2013 U.S. National Library of Medicine).
24. Hamilton E.I., Minski M.J. Abundance of the chemical elements in man's diet and possible relations with environmental factors. Sci. Total Environ. 1973, 1:375-394. (Copyright (C) 2013 American Chemical Society (ACS). All Rights Reserved).
25. Havarinasab S., Pollard K.M., Hultman P. Gold- and silver-induced murine autoimmunity-requirement for cytokines and CD28 in murine heavy metal-induced autoimmunity. Clin. Exp. Immunol. 2009, 155:567-576. (Copyright (C) 2013 U.S. National Library of Medicine).
26. Holler J.S., Nordberg G.F., Fowler B.A. Silver. Handbook on the Toxicology of Metals 2007, 809-814. Academic Press, Elsevier, UK. third ed. G.F. Nordberg, B.A. Fowler, M. Nordberg, L.T. Friberg (Eds.).
27. Hussain S.M., Hess K.L., Gearhart J.M., Geiss K.T., Schlager J.J. In vitro toxicity of nanoparticles in BRL 3A rat liver cells. Toxicol. In Vitro 2005, 19(7):975-983.
28. Hussain S.M., Javorina A.K., Schrand A.M., Duhart H.M., Ali S.F., Schlager J.J. The interaction of manganese nanoparticles with PC-12 cells induces dopamine depletion. Toxicol. Sci. 2006, 92(2):456-463.
29. ICPS Principles and Methods for the Risk Assessment of Chemicals in Food. (Environmental Health Criteria 240) 2009, WHO.
30. Jensen L.S., Peterson R.P., Falen L. Inducement of enlarged hearts and muscular dystrophy in turkey poults with dietary silver. Poult. Sci. 1974, 53(1):57-64.
31. Jeong G.N., Jo U.B., Ryu H.Y., Kim Y.S., Song K.S., Yu I.J. Histochemical study of intestinal mucins after administration of silver nanoparticles in Sprague-Dawley rats. Arch. Toxicol. 2010, 84:63-69. (Copyright (C) 2013 U.S. National Library of Medicine).
32. Kennedy A.J., Hull M.S., Bednar A.J., et al. Fractionating nanosilver: importance for determining toxicity to aquatic test organisms. Environ. Sci. Technol. 2010, 44(24):9571-9577.
33. Kim Y.S., Kim J.S., Cho H.S., et al. Twenty-eight-day oral toxicity, genotoxicity, and gender-related tissue distribution of silver nanoparticles in Sprague-Dawley rats. Inhalation Toxicol. 2008, 20:75-583. (Copyright (C) 2013 American Chemical Society (ACS). All Rights Reserved). 10.1080/08958370701874663.
34. Kim Y.S., Song M.Y., Park J.D., et al. Subchronic oral toxicity of silver nanoparticles. Part. Fibre Toxicol. 2010, 7:20. 10.1186/1743-8977-7-20.
35. Kittler S., Greulich C., Diendorf J., Koller M., Epple M. Toxicity of silver nanoparticles increases during storage because of slow dissolution under release of silver ions. Chem. Mater. 2010, 22(16):4548-4554. 10.1021/Cm100023p.
36. Kulthong K., Maniratanachote R., Kobayashi Y., Fukami T., Yokoi T. Effects of silver nanoparticles on rat hepatic cytochrome P450 enzyme activity. Xenobiotica 2012, 42(9):854-862. 10.3109/00498254.2012.670312.
37. Lansdown A.B. Critical observations on the neurotoxicity of silver. Crit. Rev. Toxicol. 2007, 37(3):237-250.
38. Lee Y., Choi J., Kim P., et al. A transfer of silver nanoparticles from pregnant rat to offspring. Toxicol. Res. (Seoul, Repub Korea) 2012, 28:139-141. (Copyright (C) 2013 American Chemical Society (ACS). All Rights Reserved). 10.5487/tr.2012.28.3.139.
39. Levine I. Physical Chemistry 2001, McGraw Hill, India. fifth ed.
40. Li P.W., Kuo T.H., Chang J.H., Yeh J.M., Chan W.H. Induction of cytotoxicity and apoptosis in mouse blastocysts by silver nanoparticles. Toxicol. Lett. 2010, 197(2):82-87.
41. Li Y., Chen D.H., Yan J., et al. Genotoxicity of silver nanoparticles evaluated using the Ames test and in vitro micronucleus assay. Mutat. Res. 2012, 745(1-2):4-10. 10.1016/j.mrgentox.2011.11.010.
42. Liu J.Y., Sonshine D.A., Shervani S., Hurt R.H. Controlled release of biologically active silver from nanosilver surfaces. ACS Nano 2010, 4(11):6903-6913. 10.1021/Nn102272n.
43. Liu J., Wang Z., Liu F.D., Kane A.B., Hurt R.H. Chemical transformations of nanosilver in biological environments. ACS Nano 2012, 6(11):9887-9899. 10.1021/nn303449n.
44. Locht L.J., Larsen A., Stoltenberg M., Danscher G. Cultured macrophages cause dissolucytosis of metallic silver. Histol. Histopathol. 2009, 24(2):167-173.
45. Locht L.J., Smidt K., Rungby J., Stoltenberg M., Larsen A. Uptake of silver from metallic silver surfaces induces cell death and a pro-inflammatory response in cultured J774 macrophages. Histol. Histopathol. 2011, 26(6):689-697.
46. Loeschner K., Hadrup N., Qvortrup K., et al. Distribution of silver in rats following 28days of repeated oral exposure to silver nanoparticles or silver acetate. Part. Fibre Toxicol. 2011, 8(1):18.
47. Maneewattanapinyo P., Banlunara W., Thammacharoen C., Ekgasit S., Kaewamatawong T. An evaluation of acute toxicity of colloidal silver nanoparticles. J. Vet. Med. Sci. 2011, 73:1417-1423. (Copyright (C) 2013 American Chemical Society (ACS). All Rights Reserved). 10.1292/jvms.11-0038.
48. Matuk Y., Ghosh M., McCulloch C. Distribution of silver in the eyes and plasma proteins of the albino rat. Can. J. Ophthalmol. 1981, 16(3):145-150.
49. McIntyre E., Wilcox J., McGill J., Lewindon P.J. Silver toxicity in an infant of strict vegan parents. J. Pediatr. Gastroenterol. Nutr. 2001, 33:501-502. (Copyright (C) 2013 U.S. National Library of Medicine).
50. Mirsattari S.M., Hammond R.R., Sharpe M.D., Leung F.Y., Young G.B. Myoclonic status epilepticus following repeated oral ingestion of colloidal silver. Neurology 2004, 62(8):1408-1410.
51. Miura N., Shinohara Y. Cytotoxic effect and apoptosis induction by silver nanoparticles in HeLa cells. Biochem. Biophys. Res. Commun. 2009, 390(3):733-737.
52. Mwilu S.K., El Badawy A.M., Bradham K., et al. Changes in silver nanoparticles exposed to human synthetic stomach fluid: effects of particle size and surface chemistry. Sci. Total Environ. 2013, 447:90-98. 10.1016/j.scitotenv.2012.12.036.
53. Navarro E., Piccapietra F., Wagner B., et al. Toxicity of silver nanoparticles to Chlamydomonas reinhardtii. Environ. Sci. Technol. 2008, 42(23):8959-8964.
54. Nielsen E., Ostergaard G., Larsen J.C. Toxicological Risk Assessment of Chemicals: A Practical Guide 2008, Informa Healthcare USA Inc., New York.
55. Nishioka H. Mutagenic activities of metal-compounds in bacteria. Mutat. Res. 1975, 31(3):185-189. 10.1016/0165-1161(75)90088-6.
56. Ohbo Y., Fukuzako H., Takeuchi K., Takigawa M. Argyria and convulsive seizures caused by ingestion of silver in a patient with schizophrenia. Psychiatry Clin. Neurosci. 1996, 50:89-90. (Copyright (C) 2013 U.S. National Library of Medicine).
57. Olcott C.T. Experimental argyrosis. 3. Pigmentation of the eyes of rats following ingestion of silver during long periods of time. Am. J. Pathol. 1947, 23(5):783-791.
58. Olcott C.T. Experimental argyrosis. 4. Morphologic changes in the experimental animal. Am. J. Pathol. 1948, 24(4):813-833.
59. Olcott C.T. Experimental argyrosis; morphologic changes in the experimental animal. Am. J. Pathol. 1948, 24(4):813-833.
60. Olcott C.T. Experimental argyrosis. 5. Hypertrophy of the left ventricle of the heart in rats ingesting silver salts. Arch. Pathol. 1950, 49(2):138-149.
61. Olcott C.T. Experimental argyrosis; hypertrophy of the left ventricle of the heart in rats ingesting silver salts. AMA Arch. Pathol. 1950, 49(2):138-149.
62. Olcott C.T., Richter G.W. Experimental argyrosis. VI. Electron microscopic study of ingested silver in the kidney of the rat. Lab. Invest. 1958, 7:103-109. (Copyright (C) 2013 U.S. National Library of Medicine).
63. Osborne O.J., Johnston B.D., Moger J., et al. Effects of particle size and coating on nanoscale Ag and TiO(2) exposure in zebrafish (Danio rerio) embryos. Nanotoxicology 2012, 10.3109/17435390.2012.737484.
64. Park E.J., Bae E., Yi J., et al. Repeated-dose toxicity and inflammatory responses in mice by oral administration of silver nanoparticles. Environ. Toxicol. Pharmacol. 2010, 30(2):162-168. 10.1016/j.etap.2010.05.004.
65. Park K., Park E.-J., Chun I.K., et al. Bioavailability and Toxicokinetics of citrate-coated silver nanoparticles in rats. Arch. Pharmacol. Res. 2011, 34:153-158. (Copyright (C) 2013 American Chemical Society (ACS). All Rights Reserved). 10.1007/s12272-011-0118-z.
66. Pelkonen K.H.O., Heinonen-Tanski H., Hanninen O.O.P. Accumulation of silver from drinking water into cerebellum and musculus soleus in mice. Toxicology 2003, 186:151-157. (Copyright (C) 2013 American Chemical Society (ACS). All Rights Reserved). 10.1016/s0300-483x(02)00743-6.
67. Pereira G. Localization of silver in the spleen of argyric rats by energy dispersive X-ray analysis coupled with scanning and transmission electron microscopy. Proc. - Annu Meet. Electron Microsc. Soc. Am. 1977, 35:504-505. (Copyright (C) 2013 American Chemical Society (ACS). All Rights Reserved).
68. Peterson R.P., Jensen L.S., Harrison P.C. Effect of silver-induced enlarged hearts during the first 4weeks of life on subsequent performance of turkeys. Avian Dis. 1973, 17(4):802-806.
69. Pratsinis A., Hervella P., Leroux J.C., Pratsinis S.E., Sotiriou G.A. Toxicity of silver nanoparticles in macrophages. Small 2013, 10.1002/smll.201202120.
70. Rogers K.R., Bradham K., Tolaymat T., et al. Alterations in physical state of silver nanoparticles exposed to synthetic human stomach fluid. Sci. Total Environ. 2012, 420:334-339. 10.1016/j.scitotenv.2012.01.044.
71. Rungby J. Experimental argyrosis: ultrastructural localization of silver in rat eye. Exp. Mol. Pathol. 1986, 45:22-30. (Copyright (C) 2013 U.S. National Library of Medicine).
72. Rungby J., Danscher G. Localization of exogenous silver in brain and spinal cord of silver exposed rats. Acta Neuropathol. 1983, 60:92-98. (Copyright (C) 2013 U.S. National Library of Medicine).
73. Rungby J., Danscher G. Hypoactivity in silver exposed mice. Acta Pharmacol. Toxicol. 1984, 55:398-401. (Copyright (C) 2013 American Chemical Society (ACS). All Rights Reserved).
74. Sardari R.R.R., Zarchi S.R., Talebi A., et al. Toxicological effects of silver nanoparticles in rats. Afr. J. Microbiol. Res. 2012, 6(27):5587-5593. 10.5897/Ajmr11.1070.
75. Scott K.G., Hamilton J.G. Metabolism of silver in the rat with radiosilver as an indicator. Univ. Calif. Publ. Pharmacol. 1950, 2:241-262. (Copyright (C) 2013 American Chemical Society (ACS). All Rights Reserved).
76. Shahare B., Yashpal M. Toxic effects of repeated oral exposure of silver nanoparticles on small intestine mucosa of mice. Toxicol. Mech. Methods 2013, 23:161-167. (Copyright (C) 2013 American Chemical Society (ACS). All Rights Reserved). 10.3109/15376516.2013.764950.
77. Shavlovski M.M., Chebotar N.A., Konopistseva L.A., et al. Embryotoxicity of silver ions is diminished by ceruloplasmin-further evidence for its role in the transport of copper. BioMetals 1995, 8:122-128. (Copyright (C) 2013 American Chemical Society (ACS). All Rights Reserved). 10.1007/bf00142011.
78. Tamimi S.O., Zmeili S.M., Gharaibeh M.N., Shubair M.S., Salhab A.S. Toxicity of a new antismoking mouthwash 881,010 in rats and rabbits. J. Toxicol. Environ. Health A 1998, 53(1):47-60.
79. van der Zande M., Vandebriel R.J., Van D.E., et al. Distribution, elimination, and toxicity of silver nanoparticles and silver ions in rats after 28-day oral exposure. ACS Nano 2012, 6:7427-7442. (Copyright (C) 2013 American Chemical Society (ACS). All Rights Reserved). 10.1021/nn302649p.
80. Vanbreemen V.L., Clemente C.D. Silver deposition in the central nervous system and the hematoencephalic barrier studied with the electron microscope. J. Biophys. Biochem. Cy 1955, 1(2):161. 10.1083/Jcb. 1.2.161.
81. Walker F. Experimental argyria: a model for basement membrane studies. Br. J. Exp. Pathol. 1971, 52(6):589-593.
82. Walker F. The deposition of silver in glomerular basement membrane. Virchows Arch. B Cell Pathol. 1972, 11:90-96. Copyright (C) 2013 U.S. National Library of Medicine).